Can peripheral blood PIP serve as a useful marker of myocardial fibrosis in patients with heart failure of hypertensive origin?
Patients with heart failure of hypertensive origin (hypertensive heart disease)
Procollagen type I propeptide (PIP) levels in peripheral blood and coronary sinus as a marker of myocardial fibrosissurrogate
Peripheral blood PIP may serve as a useful non-invasive biomarker for detecting myocardial fibrosis in patients with hypertensive heart disease and heart failure.
These findings suggest that an excess of cardiac collagen type I synthesis and deposition may be involved in the enhancement of myocardial fibrosis that accompanies the development of HF in HHD. In addition, our data show that the heart secretes PIP via the coronary sinus into the peripheral circulation in patients with HHD. Thus, PIP determined in peripheral blood can be a useful marker of myocardial fibrosis in these patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ramón Querejeta
Begoña López
Arantxa González
Circulation
Universidad de Navarra
Building similarity graph...
Analyzing shared references across papers
Loading...
Querejeta et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69d74b8ab54ccf0cfef30c7c — DOI: https://doi.org/10.1161/01.cir.0000140973.60992.9a
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: